German Cancer Consortium
- Speaker LMU:Prof. Dr. Dr. Michael von Bergwelt
- Affiliation: Department of Medicine III, LMU University Hospital, LMU Munich
Successful cancer research is inconceivable without intensive exchange between very different disciplines. Cancer research therefore often takes place at large centres, some of which in the USA have more than 10,000 employees. The German Consortium for Translational Cancer Research is oriented towards such large research centres without abandoning the federal structures of German research. Twenty-one institutions cooperate at eight locations. A core task of cancer research is to test the results of basic research for new approaches to the prevention, diagnosis and treatment of cancer. At the eight DKTK sites, scientists and physicians are committed to precisely this "translational" idea.
Munich is one of eight DKTK sites. "It is our goal to gain new insights into the biology and pathogenesis of malignant tumours in close cooperation with the other partners of the DKTK and to translate these findings into innovative methods for diagnostics and therapy. In Munich, we are focusing on tumours of the gastrointestinal tract and haematological neoplasms as well as on the analysis of oncogenic signal transduction pathways as a first step."